Authors
Ayşen Yücetürk, Nuri Peker, Esra Tığlı, Tansu Güdelci, Özge Karaosmanoğlu, Burak Elmas, İlke Özer Aslan, Bülent Tıraş
Published in
Frontiers in medicine. Volume 13. Pages 1903479. Epub Oct 28, 2026.
Abstract
Persistent poor outcomes after intracytoplasmic sperm injection (ICSI) occur in a clinically significant subset of couples despite reassuring conventional semen analysis. In such couples, testicular sperm aspiration (TESA) may be undertaken in a subsequent cycle on clinical and embryological grounds. We assessed whether TESA-ICSI improves embryo-quality indicators and live birth rates compared with EJAC-ICSI in couples whose initial EJAC-ICSI cycle did not result in a live birth.
This retrospective paired cohort study included 58 sequential ICSI cycle pairs at a single tertiary IVF center. Each pair comprised an initial ICSI cycle with ejaculated sperm (EJAC-ICSI) that had not resulted in a live birth, followed by a subsequent TESA-ICSI cycle in the same couple; the cycle pair was the unit of analysis. The primary outcome was live birth rate per cycle; secondary outcomes included fertilization, blastulation, Grade A blastocyst formation, PGT-A, clinical pregnancy, miscarriage, and live birth per embryo transfer. Paired comparisons used McNemar exact and Wilcoxon signed-rank tests.
Total oocyte, mature oocyte, 2PN, and blastocyst counts were similar between paired cycles (all p > 0.05), while the fertilization rate was lower in TESA-ICSI cycles at the oocyte level (71.3% vs. 79.7%; p = 0.001). By contrast, the blastulation rate per 2PN was higher in TESA-ICSI cycles (p = 0.008), as was the Grade A blastocyst rate both at the per-embryo level (EJAC: 2.4% vs. TESA: 8.9%; p = 0.0006) and at the per-patient level (p = 0.0032). PGT-A euploidy increased from 27.9% to 65.0% (p = 0.0009), the clinical pregnancy rate from 6.9% to 31.0% (p = 0.0026), and the live birth rate from 0% to 29.3% (absolute risk difference 29.3%; number needed to treat 3.4) (p = 1.5 × 10-5), while the miscarriage rate per clinical pregnancy fell from 4/4 to 1/18 (p = 0.0007).
In couples whose prior EJAC-ICSI cycle had not resulted in a live birth, a subsequent TESA-ICSI cycle in the same couple was associated with significant improvements in embryo quality, euploidy, and live birth without change in embryo numbers. These findings support TESA-ICSI as a reasonable therapeutic option in this clinical scenario.
PMID:
43016434
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0